Genotypic variability in patients with clinical diagnosis of Bartter syndrome type 3
- PMID: 37537162
- PMCID: PMC10400606
- DOI: 10.1038/s41598-023-38179-6
Genotypic variability in patients with clinical diagnosis of Bartter syndrome type 3
Abstract
Bartter syndrome (BS) is a salt-losing hereditary tubulopathy characterized by hypokalemic metabolic alkalosis with secondary hyperaldosteronism. Confirmatory molecular diagnosis may be difficult due to genetic heterogeneity and overlapping of clinical symptoms. The aim of our study was to describe the different molecular findings in patients with a clinical diagnosis of classic BS. We included 27 patients (26 families) with no identified pathogenic variants in CLCNKB. We used a customized Ion AmpliSeq Next-Generation Sequencing panel including 44 genes related to renal tubulopathies. We detected pathogenic or likely pathogenic variants in 12 patients (44%), reaching a conclusive genetic diagnosis. Variants in SLC12A3 were found in 6 (Gitelman syndrome). Median age at diagnosis was 14.6 years (range 0.1-31), with no history of prematurity or polyhydramnios. Serum magnesium level was low in 2 patients (33%) but urinary calcium excretion was normal or low in all, with no nephrocalcinosis. Variants in SLC12A1 were found in 3 (BS type 1); and in KCNJ1 in 1 (BS type 2). These patients had a history of polyhydramnios in 3 (75%), and the mean gestational age was 34.2 weeks (SD 1.7). The median age at diagnosis was 1.8 years (range 0.1-6). Chronic kidney disease and nephrocalcinosis were present in 1 (25%) and 3 (75%) patients, respectively. A variant in CLCN5 was found in one patient (Dent disease), and in NR3C2 in another patient (Geller syndrome). Genetic diagnosis of BS is heterogeneous as different tubulopathies can present with a similar clinical picture. The use of gene panels in these diseases becomes more efficient than the study gene by gene with Sanger sequencing.
© 2023. Springer Nature Limited.
Conflict of interest statement
The authors declare no competing interests.
Similar articles
-
Phenotype-genotype correlation in antenatal and neonatal variants of Bartter syndrome.Nephrol Dial Transplant. 2009 May;24(5):1455-64. doi: 10.1093/ndt/gfn689. Epub 2008 Dec 18. Nephrol Dial Transplant. 2009. PMID: 19096086
-
Inherited salt-losing tubulopathy: An old condition but a new category of tubulopathy.Pediatr Int. 2020 Apr;62(4):428-437. doi: 10.1111/ped.14089. Epub 2020 Apr 13. Pediatr Int. 2020. PMID: 31830341 Review.
-
Mutations in SLC12A3 and CLCNKB and Their Correlation with Clinical Phenotype in Patients with Gitelman and Gitelman-like Syndrome.J Korean Med Sci. 2016 Jan;31(1):47-54. doi: 10.3346/jkms.2016.31.1.47. Epub 2015 Dec 24. J Korean Med Sci. 2016. PMID: 26770037 Free PMC article.
-
Bartter syndrome representing digenic-based salt-losing tubulopathies presumably accelerated by renal insufficiency.CEN Case Rep. 2020 Nov;9(4):375-379. doi: 10.1007/s13730-020-00489-3. Epub 2020 Jun 6. CEN Case Rep. 2020. PMID: 32506365 Free PMC article.
-
Inherited primary renal tubular hypokalemic alkalosis: a review of Gitelman and Bartter syndromes.Am J Med Sci. 2001 Dec;322(6):316-32. doi: 10.1097/00000441-200112000-00004. Am J Med Sci. 2001. PMID: 11780689 Review.
Cited by
-
Genetic background of neonatal hypokalemia.Pediatr Nephrol. 2024 Sep 16. doi: 10.1007/s00467-024-06492-5. Online ahead of print. Pediatr Nephrol. 2024. PMID: 39283520 Review.
References
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources